Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Consult a healthcare provider before acting on any information here
And by day 21, only about 35 percent of the original active compound remains
Objective markers (IGF-1, metabolic panels, and where tested, biological age) typically show measurable improvement
FOXO4-DRI is a large peptide (~5382 Da, 48 amino acids) with a critical structural modification: the D-Retro-Inverso (DRI) design uses D-amino acids in reversed sequence to confer protease resistance while maintaining the 3D spatial arrangement needed for target binding
5.4% WL with semaglutide 1 mg and 1.2% WL with placebo at 16 weeks (phase 2 trial) [69]
US$ 24.62
US$ 20.85
US$ 29.53
US$ 26.73
